Sath Shukla, EVP & CFO at Alaunos Therapeutics, holds 1.18M shares in Spero Therapeutics (Ticker: SPRO), holds 80.50K shares in Alaunos Therapeutics (Ticker: TCRT).

See the Hottest Stocks Based on Insider Trading >

Sath Shukla
Alaunos Therapeutics (TCRT)
EVP & CFO

Ranked #47,516 out of 98,564 Corporate Insiders

Profitable Transactions

2 out of 2 Profitable Transactions

Average Return

+2.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

94.17%

SPRO

5.83%

TCRT

A breakdown of Sath Shukla's holdings

See the Top Stocks by Insiders

Insider Roles

Spero Therapeutics
(SPRO)

CEO & President, Director

Alaunos Therapeutics
(TCRT)

EVP & CFO

Roles that Sath Shukla holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Spero Therapeutics
(SPRO)

Rating:Informative Sell

Date:Aug 30, 2023 - Today

Return:+2.70%

The most profitable trade made by Sath Shukla

See the Latest Stocks Traded by Insiders

Sath Shukla's Trading History

TCRT

Alaunos Therapeutics

Jan 31, 2020

EVP & CFO

Uninformative Buy

―

$106.26K

SPRO

Spero Therapeutics

Feb 05, 2024

CEO & President, Director

Uninformative Buy

―

$1.72M

List of latest transactions for each holding click on a transaction to see Sath Shukla's performance on stock

See All Insider Trading from Today

Sath Shukla insider profile FAQ

What is the percentage of profitable transactions made by Sath Shukla?

The percentage of profitable transactions made by Sath Shukla is 100%.

What is the average return per transaction made by Sath Shukla?

The average return per transaction made by Sath Shukla is 2.70%.

What stocks does Sath Shukla hold?

Sath Shukla holds: TCRT, SPRO stocks.

What was Sath Shukla’s latest transaction?

Sath Shukla latest transaction was an Uninformative Buy of ―.

What was Sath Shukla's most profitable transaction?

Sath Shukla’s most profitable transaction was an Informative Sell of SPRO stock on August 30, 2023. The return on the trade was 2.70%.

What is Sath Shukla's role in Alaunos Therapeutics?

Sath Shukla's role in Alaunos Therapeutics is EVP & CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Sath Shukla Insider Profile

Sath Shukla Alaunos Therapeutics (TCRT)EVP & CFO